We propose a wide portfolio
of radiopharmaceutical tracers
Nucleis is a radiopharmaceutical company which propose and manufacture Radiopharmaceutical Drugs for Diagnostic and Therapy Monitoring.
Nucleis is a spin-off from the University of Liège (Cyclotron Research Centre - Belgium) created to outsource the GMP manufacturing and distribution of PET (*Positron Emission Tomography) radiopharmaceutical drugs.
Our core business consists of three main activities:
- FDG manufacturing and distribution. Glucotrace (fludeoxyglucose (18F))
- Manufacturing and distribution of IP drugs as part of our CMO activities.
- Manufacturing and distribution of generic pharmaceutical drugs for clinical trials. Investigational Medicinal Products - IMP and non-IMP